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Hydrogen sulﬁde prodrugs—a review
Yueqin Zheng, Xingyue Ji, Kaili Ji, Binghe Wang
Department of Chemistry and Center for Diagnostics and Therapeutics,
Georgia State University, Atlanta, GA 30303, USAHydrogen sulﬁde (H2S) is recognized as one of three gasotransmitters together with
nitric oxide (NO) and carbon monoxide (CO). As a signaling molecule, H2S plays
an important role in physiology and shows great potential in pharmaceutical applications.
Along this line, there is a need for the development of H2S prodrugs for various reasons.
In this review, we summarize different H2S prodrugs, their chemical properties, and some
of their potential therapeutic applications.Acta Pharmaceutica Sinica B, 5 (2015) 378
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud, Wei Li
Department of Pharmaceutical Sciences, College of Pharmacy, the University
of Tennessee Health Science Center, Memphis, TN 38163, USAHypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer drug
target. This review summarizes the role and regulation of the HIF-1α in cancer and
recent therapeutic approaches targeting this important pathway.
Acta Pharmaceutica Sinica B, 5 (2015) 390
Mechanisms of resistance to EGFR tyrosine kinase inhibitors
Lihua Huang, Liwu Fu
State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-Sen
University, Guangzhou 510060, ChinaWe review and summarize the known resistant mechanisms to EGFR-TKIs and provide potential
targets for development of new therapeutic strategies.
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Cancer metastases: challenges and opportunities
Xiangming Guan
Department of Pharmaceutical Sciences, College of Pharmacy, South Dakota
State University, Brookings, SD 57007, USACancer metastasis is the major cause of cancer morbidity and mortality, and accounts for
about 90% of cancer deaths. Limited progress has been made in the treatment of cancer
metastasis due to various factors. This review is aimed to provide an overview of the
metastasis process and targets for intervention with a focus on cancer cell detachment,
migration, invasion and adhesion. It is hoped that this review can serve as a lead for
readers who are interested in cancer metastasis and intervention.Acta Pharmaceutica Sinica B, 5 (2015) 419
New small-molecule drug design strategies for ﬁghting resistant inﬂuenza A
Zuyuan Shena, Kaiyan Loua, Wei Wanga,b
aShanghai Key Laboratory of Chemical Biology, School of Pharmacy, and State
Key Laboratory of Bioengineering Reactor, East China University of Science and
Technology, Shanghai 200237, China
bDepartment of Chemistry and Chemical Biology, University of New Mexico,
Albuquerque, NM 87131-0001, USAInﬂuenza A virus is the major cause of seasonal or pandemic ﬂu worldwide. The continuous
evolvement of inﬂuenza A virus and the rapid emergence of resistance to current drugs,
particularly to amantadine, rimantadine, and oseltamivir, have raised an urgent need for
developing new anti-inﬂuenza drugs against resistant forms of inﬂuenza A virus. In this review, we ﬁrst give a brief introduction of the molecular
mechanisms behind resistance, and then discuss new strategies in small-molecule drug development to overcome inﬂuenza A virus resistance targeting
mutant M2 proteins and neuraminidases, and other viral proteins not associated with current drugs.Acta Pharmaceutica Sinica B, 5 (2015) 431
Adenine: an important drug scaffold for the design of antiviral agents
Changyuan Wang, Zhendong Song, Haiqing Yu, Kexin Liu, Xiaodong Ma
College of Pharmacy, Dalian Medical University, Dalian 116044, China
Adenine derivatives, in particular the scaffold bearing the acyclic nucleoside phosphonates
(ANPS), possess signiﬁcant antiviral and cytostatic activity. Till now, several effective adenine
derivatives have been marketed for the treatment of HIV, HBV, CMV and other virus-infected
diseases. Here, we systematically summarized the structure-activity relationships (SARs)
of the adenine derivatives, and gave important information for further optimizing this template.Acta Pharmaceutica Sinica B, 5 (2015) 442
Insoluble drug delivery strategies: review of recent advances and business prospects
Sandeep Kalepua, Vijaykumar Nekkantib
aDepartment of Pharmaceutical Technology, Shri Vishnu College of Pharmacy, Bhimavaram 534202,
Andhra Pradesh, India
bCollege of Pharmaceutical Sciences, Western University of Health Sciences, Pomona, California
91766, USAThe improved formulation of existing drugs is turning out to be lucrative business for pharmaceutical industry
which is facing innovation deﬁcit these days for new molecules. New dosage form, change of forms of drugs
(ester/salt), prodrug/active metabolite of drug, different routes of administration are few changes that pharmaceutical
companies are exploring for 505(b)(2) ﬁllings. Signiﬁcant number of insoluble drugs in the market provides proﬁtable
strategies for pharmaceutical companies to ﬁle NDA under 505(b)(2) with improved formulations providing faster dissolution and enhanced
bioavailability. Hence this review summarizes various solubilization technologies. The recent advances, clinical beneﬁts and business potentials of these
technologies are discussed in detail.
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Calycosin-7-O-β-D-glucopyranoside stimulates osteoblast differentiation through regulating
the BMP/WNT signaling pathways
Jing Jian, Lijuan Sun, Xun Cheng, Xiaofang Hu, Jichao Liang, Yong Chen
Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, Hubei
Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei University, Wuhan
430062, ChinaThe results indicate that calycosin-7-O-β-D-glucopyranoside (CG) promotes the osteoblastic differentiation of ST2 cells
through regulating the BMP/WNT signaling pathways. On this basis, CG may be a useful lead compound for improving
the treatment of bone-decreasing diseases and enhancing bone regeneration.
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Determination of ginsenoside compound K in human plasma by liquid
chromatography–tandem mass spectrometry of lithium adductsYunhui Chen a,b, Youming Lub, Yong Yangb, Xiaoyan Chenb, Liang Zhua, Dafang Zhongb
aGuangdong College of Pharmacy, Guangzhou 510006, China
bShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203,
ChinaGinsenoside compound K (GCK), the main metabolite of protopanaxadiol constituents of Panax
ginseng, easily produces alkali metal adduct ions during mass spectrometry particularly with lithium.
Accordingly, a rapid and sensitive liquid chromatography–tandem mass spectrometric method was
developed for analysis of GCK in human plasma based on formation of a lithium adduct. The method
was successfully applied to a pharmacokinetic study involving administration of a single GCK 50 mg tablet
to healthy Chinese volunteers.Acta Pharmaceutica Sinica B, 5 (2015) 467
Validated LC-MS/MS method for determination of YH-8, a novel PKnB inhibitor,
in rat plasma and its application to pharmacokinetic study
Qianqian Zhaia,b, Jing Panga, Guoqing Lia, Congran Lia, Xinyi Yanga, Liyan Yua,
Yucheng Wanga, Jian Lib, Xuefu Youa
aInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking
Union Medical College, Beijing 100050, China
bKey Laboratory of Sustainable Development of Marine Fisheries, Ministry of Agriculture,
Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao
266071, China(E)-Methyl-4-aryl-4-oxabut-2-enoate (YH-8) is a novel PKnB protein kinase inhibitor with good anti-tuberculosis activity. To evaluate its
pharmacokinetics in rats, a sensitive and selective high performance a liquid chromatography–tandem mass spectrometric (LC–MS/MS) method has
been developed and validated for the quantiﬁcation of YH-8 in rat plasma for the ﬁrst time.Acta Pharmaceutica Sinica B, 5 (2015) 473
Cloning, expression and characterization of COI1 gene (AsCOI1) from
Aquilaria sinensis (Lour.) Gilg
Yongcui Liaoa, Jianhe Weia,b, Yanhong Xua, Zheng Zhanga,b
aInstitute of Medicinal Plant Development, Chinese Academy of Medical Sciences
& Peking Union Medical College, Beijing 100193, China
bHainan Branch Institute of Medicinal Plant (Hainan Provincial Key Laboratory of
Resources Conservation and Development of Southern Medicine), Chinese Academy
of Medical Sciences and Peking Union Medical College, Wanning 571533, ChinaThis paper characterizes the basic function about AsCOI1 gene including the full-length cDNA
sequence cloning, informatics prediction analysis, tissue expression pattern analysis, subcellular localization analysis, and the wounding-induced
expression analysis. AsCOI1 gene responded to different stresses; it belongs to an early wound-responsive gene, and it may be playing some role in
agarwood formation.
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Simultaneous determination of 3-chlorotyrosine and 3-nitrotyrosine in
human plasma by direct analysis in real time–tandem mass spectrometry
Yuqiao Songa, Jie Liaoa, Cheng Zhaa, Bin Wanga, Charles C. Liub
aMedical Experiment and Analysis Center of PLA General Hospital, Beijing
100853, China
bASPEC Technologies Limited Beijing, Beijing, 100102, ChinaA novel method for the simultaneous determination of 3-nitrotyrosine (NT) and 3-chlorotyrosine (CT) in human plasma has been developed based on
direct analysis in real time–tandem mass spectrometry (DART–MS/MS). The method is potentially useful for high throughput analysis.Acta Pharmaceutica Sinica B, 5 (2015) 487
Interactions among SARS-CoV accessory proteins revealed by bimolecular
ﬂuorescence complementation assay
Jianqiang Konga, Yanwei Shia, Zhifang Wanga, Yiting Panb
aState Key Laboratory of Bioactive Substance and Function of Natural Medicines &
Ministry of Health Key Laboratory of Biosynthesis of Natural Products, Institute of
Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College,
Beijing 100050, China
bSchool of Chemical Engineering, Beijing Institute of Petrochemical Technology, Beijing
102617, ChinaTwo non-ﬂuorescent fragments (VN and VC) derived from a ﬂuorescent protein EYFP were separately attached to two accessory proteins of SARS-CoV
(APs) and the resulting fusion proteins were co-expressed in Saccharomyces cerevisiae. When the two accessory proteins interact, the split EYFP
fragments can be functionally reconstituted, allowing a ﬂuorescent readout. Thereby, the BiFC method can be used for direct visualization of accessory
protein interactions in living cells.
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Cover story
Binghe Wang
Hydrogen sulﬁde (H2S), ﬁrst discovered in 17
th century by Carl Wilhelm Scheele, is well known as a toxic air pollutant with an odor of rotten eggs.
However, H2S has recently been recognized as one of the gasotransmitters in mammals, which plays critical roles in biological processes. To examine
the complex biological functions of H2S, H2S releasing molecules (H2S prodrugs) are needed. Besides being excellent research tools, these H2S prodrugs
have also shown therapeutic potentials in the control of cancer, vasodilation, and inﬂammation, among others. In this review, we summarize different
H2S prodrugs, their chemical properties, and some of their potential therapeutic applications.
